Durect Corporation is a biopharmaceutical company focused on developing innovative therapeutics based on its proprietary drug delivery technology platforms. The company specializes in formulating and delivering advanced medicines with an emphasis on treating chronic pain, liver diseases, and various central nervous system disorders. Durect's pipeline includes both proprietary drug candidates and partnerships that leverage its expertise in drug formulation and delivery systems, aimed at improving patient outcomes and enhancing the efficacy of existing therapies. Through its research and development efforts, Durect seeks to address significant unmet medical needs with its advanced drug delivery solutions. Read More
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling around 80 points on Wednesday The Dow traded down 0.23% to 34,074.30 while the NASDAQ fell 0.01% to 13,638.07. The S&P 500 also fell, dropping, 0.01% to 4,378.16.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 100 points on Wednesday The Dow traded down 0.33% to 34,038.81 while the NASDAQ fell 0.28% to 13,601.60. The S&P 500 also fell, dropping, 0.24% to 4,367.92.
U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Wednesday Following the market opening Wednesday, the Dow traded up 0.27% to 34,244.50 while the NASDAQ rose 0.20% to 13,667.28. The S&P 500 also rose, gaining, 0.25% to 4,389.24.
